DAV announced a partnership with Americans for Ibogaine aimed at advancing research and policy advocacy related to ibogaine and veteran health outcomes. The effort focuses on building evidence and supporting policy discussions relevant to veterans’ treatment options.
Read full story at DAV (Disabled American Veterans) →Also reported by
Related Topics
veteransdavmental-healthptsdsubstance-use-disorderibogaineresearchadvocacy